Effects of interferon-γ and tumour necrosis factor-α on CD95/Fas ligand-mediated apoptosis in human blood eosinophils

Scandinavian Journal of Immunology

Volumn 51, Issue 1, 2000, Pages 54-59

  Luttmann, W ^a   Dauer, E ^a   Schmidt, S ^b   Marx, O ^a   Hossfeld, M ^b   Matthys, H ^a   Virchow, Jr ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; DOSE RESPONSE; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FAS LIGAND PROTEIN; HUMANS; INTERFERON-GAMMA, RECOMBINANT; JURKAT CELLS; KINETICS; MEMBRANE GLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033959193     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00645.x     Document Type: Article

References (29)

1. 1 Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. 2 Osborne BA. Apoptosis and the maintenance of homoeostasis in the immune system. Curr Opin Immunol 1996;8:245-54.
3. 3 Krammer PH, Dhein J, Walczak H et al. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994;142:175-91.
4. 4 Nagata S, Golstein P. The Fas death factor. Science 1995 ;267:1449-56.
5. 5 Miyawaki T, Uehara T, Nibu R et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992;149:3753-8.
6. 6 Matsue H, Kobayashi H, Hosokawa T, Akitaya T, Ohkawara A. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch Dermatol Res 1995;287:315-20.
7. 7 Leithauser F, Dhein J, Mechtersheimer G et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-29.
8. 8 Galle PR, Hofmann WJ, Walczak H et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
9. 9 Oishi M, Maeda K, Sugiyama S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch Dermatol Res 1994;286:396-407.
10. 10 Hahne M, Renno T, Schroeter M et al. Activated B cells express functional Fas ligand. Eur J Immunol 1996;26:721-4.
11. 11 Nakajima M, Nakajima A, Kayagaki N, Honda M, Yagita H, Okumura K. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin Immunol Immunopathol 1997;83:223-9.
12. 12 Luttmann W, Opfer A, Dauer E et al. Differential regulation of CD95 (FAS/APO-1) expression in human blood eosinophils. Eur J Immunol 1998;28:2057-65.
13. 13 Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-43.
14. 14 Tsuyuki S, Bertrand C, Erard F et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995;96:2924-31.
15. 15 Simon HU, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 1995;16:53-5.
16. 16 Hebestreit H, Yousefi S, Balatti I et al. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol 1996;26:1775-80.
17. 17 Kimura I, Moritani Y, Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973;3:195-202.
18. 18 Luttmann W, Knoechel B, Foerster M, Matthys H, Virchow JC Jr, Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol 1996;157:1678-83.
19. 19 Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996;87:2822-30.
20. 20 von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH, Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998;58:526-34.
21. 21 Novelli F, Bernabei P, Ozmen L et al. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha-and beta-chains of its receptor. J Immunol 1996;157:1935-43.
22. 22 Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma (-/-) mice, but not in TNF-alpha (-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997;159:1418-28.
23. 23 Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 1996;229:21-6.
24. 24 Ossina NK, Cannas A, Powers VC et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272:16351-7.
25. 25 Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990;145:2950-8.
26. 26 Dibbert B, Daigle I, Braun D et al. Role for bcl-X (L) in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998;92:778-83.
27. 27 Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
28. 28 Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J Biol Chem 1997;272:17255-7.
29. 29 Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-5.